By Judith E. Karp
This is a well timed compilation of latest recommendations within the molecular pathogenesis and molecular treatment of acute myelogenous leukemia (AML). the point of interest is on chosen severe molecular determinants of AML pathogenesis and pathophysiology and the exploitation of those components via assorted healing brokers and modalities. there's an emphasis all through at the bidirectional circulation of data among the medical and laboratory arenas.
Read or Download Acute Myelogenous Leukemia (Contemporary Hematology) PDF
Best hematology books
The microvasculature refers back to the smallest blood vessels, arterial and venous, that nurture the tissues of every organ. except shipping, additionally they give a contribution to the systematic legislation of the physique. In daily terminology, the microcirculation is "where the motion is. " Microcirculation is without delay occupied with such disorder states as Alzheimers, irritation, tumor development, diabetic retinopathy, and wound therapeutic- plus cardiovascular health is at once with regards to the formation of recent capillaries in huge muscular tissues.
There are various stable heme books out there and i've loads of them. i feel lots of them are redundant. notwithstanding there aren't many solid heme books on circulation. this e-book isn't in line with illnesses kinds yet on movement styles. it provides readers a bird's eye view on the right way to technique a heme case. i will do a heme fellowship quickly.
This ebook, in Q&A layout, addresses a variety of clinically proper issues and concerns in Nonmalignant Hematology, or “Benign Hematology,” as a way to delivering a strong, enticing device that would support each hematologist and oncologist (pediatric and grownup both) in making judgements in the course of day by day perform.
This publication sheds new gentle on scientific, organic and healing facts at the infrequent sickness Waldenström’s Macroglobulinemia (WM) with the participation of widely-recognized specialists, concerned about this box. It represents the efforts of physicians, scientists and sufferers, all over the international, to higher comprehend and treatment this infrequent sickness.
- Cell Membrane. the Red Blood Cell as a Model
- Stem Cells And Myocardial Regeneration
- Hemolytic Anemia in Disorders of Red Cell Metabolism
- Giant Cell Arteritis - A Medical Dictionary, Bibliography, and Annotated Research Guide to Internet References
- Gene Therapy for Cancer
Extra resources for Acute Myelogenous Leukemia (Contemporary Hematology)
Diphtheria toxin-interleukin-3 fusion protein (DT(388)IL3;prolongs disease-free survival of leukemic immunocompromised mice. Leukemia 2003;17:155-159. Giles Fl, Kantarjian H, Cortes 1. Novel therapies for patients with chronic myeloid leukemia. Exp Rev Anticancer Ther 2004;4(2):271-282. Aguayo A, Kantarjian H, Manshouri T, et al. Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes. Blood 2000;96:2240-2245. Hussong JW, Rodgers GM, Shami PI. Evidence of increased angiogenesis in patients with acute myeloid leukemia.
Clin. Cancer Res 2004;10(10):3371-3376. Erratum in: Clin Cancer Res 2004;10(22):7787. 22 Part I I Ravandi and Giles 164. Sonneveld P. Multidrug resistance in hematological malignancies. J Intern Med 2000;247:521-534. 165. Ueda K, Cardarelli C, Gottesman MM, Pastan I. Expression of a full-length cDNA for the human "MDRl" gene confers resistance to colchicine, doxorubicin, and vinblastine. Proc Natl Acad Sci USA 1987;84: 3004-3008. 166. Nooter K, Sonneveld P, Oostrum R, Herweijer H, Hagenbeek T, Valerio D.
Cancer Res 1999;59:2615-2622. 162. Cortes JE, Estey E, Giles FJ, et al. Phase I study of Bortezomib (PS-341, VELCADE), a proteasome inhibitor, in patients with refractory or relapsed acute leukemias and myelodysplastic syndromes. Blood 2002; 100:560. 163. Cortes J, Thomas D, Koller C, et al. Phase I study of bortezomib in refractory or relapsed acute leukemias. Clin. Cancer Res 2004;10(10):3371-3376. Erratum in: Clin Cancer Res 2004;10(22):7787. 22 Part I I Ravandi and Giles 164. Sonneveld P. Multidrug resistance in hematological malignancies.